MoneyWorks4Me

The revenue for the September 2022 quarter is pegged at Rs. 19280.00 millions, about 7.17% up against Rs. 17990.00 millions recorded during the year-ago period.The Net proft of the company remain more or less same to Rs. 2720.00  millions from Rs. 3260.00 millions ,decline by -16.56%.A decline of 6310.00 millions was observed in the OP in the quarter ended September 2022 from 6710.00 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 19280.00 17990.00 7.17 38610.00 34940.00 10.50 67420.00 64510.00 4.51
Other Income 110.00 540.00 -79.63 400.00 1040.00 -61.54 2040.00 1180.00 72.88
PBIDT 6310.00 6710.00 -5.96 13250.00 12990.00 2.00 23040.00 23100.00 -0.26
Interest 620.00 640.00 -3.13 1130.00 1300.00 -13.08 2360.00 3340.00 -29.34
PBDT 5690.00 6070.00 -6.26 12120.00 11690.00 3.68 20680.00 19760.00 4.66
Depreciation 1560.00 1530.00 1.96 3050.00 3030.00 0.66 6020.00 6100.00 -1.31
PBT 4130.00 4540.00 -9.03 9070.00 8660.00 4.73 14660.00 13660.00 7.32
TAX 1410.00 1280.00 10.16 3080.00 2660.00 15.79 4750.00 2280.00 108.33
Deferred Tax 710.00 490.00 44.90 1520.00 1150.00 32.17 2220.00 -200.00 -1210.00
PAT 2720.00 3260.00 -16.56 5990.00 6000.00 -0.17 9910.00 11380.00 -12.92
Equity 1692.30 846.20 99.99 1692.30 846.20 99.99 846.20 846.20 0.00
PBIDTM(%) 32.73 37.30 -12.25 34.32 37.18 -7.69 34.17 35.81 -4.56
Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1195.10
Cipla 1303.30
Lupin 1960.00
Zydus Lifesciences 1115.10
View more..